Acceptance and perceived value of non-invasive malaria diagnostic tests in malaria-endemic countries

Malaria Journal

Table 2 Key product characteristics to be prioritized

Product characteristic	Priority	Percentage*
Plasmodium spp. detection
	Pan/P. falciparum	40.0 %
	P. falciparum/P. vivax	46.0 %
Price per purpose		< $0.50	> $0.50
Saliva-based	Largely replace both conventional RDTs and microscopy	32.00 %	0.76 %
	Largely replace conventional RDTs	41.00 %	17.42 %
Urine-based	Largely replace both conventional RDTs and microscopy	16.90 %	5.16 %
	Largely replace conventional RDTs	25.35 %	15.02 %
Stability at 40 °C
	Absolutely essential	76.0 %
	Probably not needed	1.0 %
Ability to detect sub–microscopic infections
	Absolutely essential	74.0 %
	Probably not needed	3.0 %
Can be used by untrained lay people
	Absolutely essential	74.0 %
	Probably not needed	1.0 %
Shelf-life
24 month shelf–life	Absolutely essential	66.0 %
	Probably not needed	1.0 %
18 month shelf–life	Absolutely essential	43.0 %
	Probably not needed	14.0 %
Time to results: faster than current RDTs
	Absolutely essential	46.0 %
	Probably not needed	9.0 %
Quantitative results
	Absolutely essential	31.0 %
	Probably not needed	10.0 %

Bold values “<0.50” and “>0.50” represent categories for which answers are given below (for instance 32% of respondant think that saliva based test will “largely replace conventional RDTs and microscopy”
*Percentages do not add up to 100 because only the two most relevant options are presented here

ISSN: 1475-2875